收稿日期: 2022-12-03
网络出版日期: 2024-04-10
基金资助
国家重点研发计划(2022YFC2703504)
Clinical characteristics of pregnancy complicated with inflammatory bowel disease
Received date: 2022-12-03
Online published: 2024-04-10
Supported by
the National Key Research and Development Program of China(2022YFC2703504)
目的: 分析炎症性肠病(inflammatory bowel diseases,IBD)病例妊娠前、妊娠期及哺乳期的临床特点。方法: 收集2011年9月至2022年6月北京大学第三医院产科收治的妊娠合并IBD并分娩的病例资料,回顾分析其临床特点;按照妊娠前、妊娠期及哺乳期的疾病状态分为疾病活动组和缓解组,比较两组妊娠前咨询、营养状况、妊娠及分娩并发症、分娩孕周、分娩方式及新生儿结局。结果: 共纳入妊娠合并IBD 33位,其中7位分娩二胎,共40例分娩,包括自然受孕36例(90.0%)和辅助生殖4例(10.0%)。40例分娩中,妊娠前、妊娠期及哺乳期IBD持续处于缓解期21例(52.5%),活动期19例(47.5%),其中8例(42.1%)因自行停用药物或未按医嘱规律服药疾病发生活动。疾病缓解组与活动组相比,妊娠前咨询率更高(57.1% vs. 15.8%,P=0.010),血红蛋白[(112.67±8.53) g/L vs. (102.84±5.23) g/L,P<0.001]、血清总蛋白[(66.58±6.34) g/L vs. (60.83±6.25) g/L,P=0.006]、血清白蛋白[36.4(35.1,38.3) g/L vs. 34.3(31.1,35.6) g/L,P=0.006]、血钙[(2.25±0.10) μmol/L vs. (2.13±0.15) μmol/L,P=0.004]水平更高,妊娠期高血压疾病发生率更低(0 vs. 31.6%,P=0.007)。40例中经阴道分娩27例(67.5%),剖宫产13例(32.5%)。新生儿结局分析结果表明,足月产38例,早产2例;巨大儿1例,小于胎龄儿1例,低出生体重儿1例,出生缺陷3例;转入新生儿重症监护病房10例,其中新生儿感染4例,新生儿黄疸2例。结论: 妊娠前咨询和评估对IBD患者至关重要,经过妊娠期精细管理,大多数病例可以得到良好的妊娠结局。
马会超 , 李军 , 王永清 . 妊娠合并炎症性肠病的临床特点[J]. 北京大学学报(医学版), 2024 , 56(2) : 260 -266 . DOI: 10.19723/j.issn.1671-167X.2024.02.009
Objective: To analyze the clinical characteristics of patients with inflammatory bowel diseases (IBD) in pre-pregnancy, pregancy and loctation. Methods: The clinical data of pregnancy complicated with IBD in Department of Obstetrics and Gynecology of Peking University Third Hospital and deli-very from September 2011 to June 2022 were collected. The clinical characteristics of the patients were analyzed retrospectively. According to the state of diseases during pre-pregnancy, pregnancy and lactation, the patients were divided into active and remission group, and the two groups were compared interms of pre-pregnancy counseling, nutritional status, pregnancy and delivery complications, gestational week, mode of delivery, and neonatal outcome. Results: A total of 33 pregnant women with IBD were included in this study, of which 7 delivered a second child, for a total of 40 deliveries, with 36 natural pregnancies (90.0%) and 4 assisted reproductions (10.0%). Among the 40 cases, 21 cases (52.5%) were sustained in remission in pre-pregnancy, pregnancy and lactation, and 19 cases (47.5%) in disease activity, of which 8 cases (42.1%) were due to self-withdrawal of drugs or failure to take medicine regularly. Compared with the activity group, the disease remission group had a higher rate of pre-pregnancy counseling (57.1% vs. 15.8%, P=0.010), and higher levels of hemoglobin [(112.67±8.53) g/L vs. (102.84±5.23) g/L, P < 0.001], serum total protein [(66.58±6.34) g/L vs. (60.83±6.25) g/L, P=0.006], serum albumin [36.4 (35.1, 38.3) g/L vs. 34.3 (31.1, 35.6) g/L, P=0.006], serum calcium [(2.25±0.10) μmol/L vs. (2.13±0.15) μmol/L, P=0.004], but a lower incidence of gestational hypertensive disorders (0 vs. 31.6%, P=0.007). In 40 deliveries, there were 27 cases of vaginal delivery (67.5%), 13 cases of cesarean section (32.5%). The analysis of neonatal outcomes showed 38 full-term deliveries and 2 preterm deliveries; 1 case of macrosomia, 1 case of small-for-gestational-age, 1 case of low birth weight and 3 cases of birth defects. There were 10 newborns admitted to neonatal intensive care unit, including 4 cases of neonatal infections and 2 cases of neonatal jaundice. Conclusion: Pre-pregnancy counseling and evaluation of IBD patients are very important, and good pregnancy outcomes can be obtained through careful management during pregnancy in the most of the patients.
| 1 | van der Giessen J , Huang VW , van der Woude CJ , et al. Modulatory effects of pregnancy on inflammatory bowel disease[J]. Clin Transl Gastroenterol, 2019, 10 (3): e00009. |
| 2 | Bandoli G , Singh N , Strouse J , et al. Mediation of adverse pregnancy outcomes in autoimmune conditions by pregnancy complications: A mediation analysis of autoimmune conditions and adverse pregnancy outcomes[J]. Arthritis Care Res (Hoboken), 2020, 72 (2): 256- 264. |
| 3 | Torres J , Chaparro M , Julsgaard M , et al. European Crohn's and colitis guidelines on sexuality, fertility, pregnancy, and lactation[J]. J Crohns Colitis, 2023, 17 (1): 1- 27. |
| 4 | 中华医学会消化病学分会炎症性肠病学组. 炎症性肠病诊断与治疗的共识意见(2018年, 北京)[J]. 中华消化杂志, 2018, 38 (5): 292- 311. |
| 5 | 谢幸, 孔北华, 段涛, 等. 妇产科学[M]. 9版 北京: 人民卫生出版社, 2018. |
| 6 | 中国营养学会. 中国妇女妊娠期体重监测与评价: T/CNSS 009—2021[S]. 北京: 中国营养学会, 2021: 1-4. |
| 7 | Laube R , Yau Y , Selinger CP , et al. Knowledge and attitudes towards pregnancy in females with inflammatory bowel disease: An international, multi-centre study[J]. J Crohns Colitis, 2020, 14 (9): 1248- 1255. |
| 8 | 中华医学会消化病学分会炎症性肠病学组. 炎症性肠病妊娠期管理的专家共识意见[J]. 中华炎性肠病杂志(中英文), 2019, 3 (4): 284- 295. |
| 9 | 中华医学会消化病学分会炎症性肠病学组, 中华医学会肠外与肠内营养学分会胃肠病与营养协作组. 炎症性肠病营养支持治疗专家共识(第二版)[J]. 中华炎性肠病杂志(中英文), 2018, 2 (3): 154- 172. |
| 10 | Bell SJ , Flanagan EK . Updates in the management of inflammatory bowel disease during pregnancy[J]. Med J Aust, 2019, 210 (6): 276- 280. |
| 11 | Zhang Y , Zhang L , Gao X , et al. Validation of the GLIM criteria for diagnosis of malnutrition and quality of life in patients with inflammatory bowel disease: A multicenter, prospective, observational study[J]. Clin Nutr, 2022, 41 (6): 1297- 1306. |
| 12 | Ives CW , Sinkey R , Rajapreyar I , et al. Preeclampsia-patho-physiology and clinical presentations: JACC state-of-the-art review[J]. J Am Coll Cardiol, 2020, 76 (14): 1690- 1702. |
| 13 | Tarar ZI , Farooq U , Zafar MU , et al. A national study of pregnancy- related maternal and fetal outcomes in women with inflammatory bowel disease[J]. Int J Colorectal Dis, 2022, 37 (7): 1535- 1543. |
| 14 | Stevens GA , Finucane MM , De-Regil LM , et al. Global, regio-nal, and national trends in haemoglobin concentration and prevalence of total and severe anaemia in children and pregnant and non-pregnant women for 1995-2011: A systematic analysis of population-representative data[J]. Lancet Glob Health, 2013, 1 (1): e16- e25. |
| 15 | 赵思宇, 景文展, 刘珏, 等. 中国妇女2012—2016年妊娠期贫血患病状况的Meta分析[J]. 中华预防医学杂志, 2018, 52 (9): 951- 957. |
| 16 | Abdul SA , West J , Ban L , et al. Adverse pregnancy outcomes among women with inflammatory bowel disease: A population-based study from England[J]. Inflamm Bowel Dis, 2016, 22 (7): 1621- 1630. |
| 17 | Meyer A , Drouin J , Weill A , et al. Pregnancy in women with inflammatory bowel disease: A French nationwide study 2010-2018[J]. Aliment Pharmacol Ther, 2020, 52 (9): 1480- 1490. |
| 18 | Chaparro M , Kunovsky L , Aguas M , et al. Surgery due to inflammatory bowel disease during pregnancy: Mothers and offspring outcomes from an ECCO confer multicentre case series [scar study][J]. J Crohns Colitis, 2022, 16 (9): 1428- 1435. |
| 19 | 国家卫生和计划生育委员会办公厅. 早产儿保健工作规范[J]. 中华围产医学杂志, 2017, 20 (6): 6. |
| 20 | Li HT , Hellerstein S , Zhou YB , et al. Trends in cesarean delivery rates in China, 2008-2018[J]. JAMA, 2020, 323 (1): 89- 91. |
| 21 | Burgess CJ , Schnier C , Wood R , et al. Prematurity, delivery method, and infant feeding type are not associated with paediatric-onset inflammatory bowel disease risk: A Scottish retrospective birth cohort study[J]. J Crohns Colitis, 2022, 16 (8): 1235- 1242. |
| 22 | Foulon A , Dupas JL , Sabbagh C , et al. Defining the most appropriate delivery mode in women with inflammatory bowel disease: A systematic review[J]. Inflamm Bowel Dis, 2017, 23 (5): 712- 720. |
| 23 | Lever G , Chipeta H , Glanville T , et al. Perineal outcomes after delivery in 179 mothers with inflammatory bowel disease compared to 31 258 controls: A single-centre cohort study[J]. J Crohns Colitis, 2022, 16 (3): 511- 514. |
| 24 | Burnett D , Brown MM , Otley A , et al. The association between caesarean section and inflammatory bowel disease in childhood and young adulthood: Findings from 2 retrospective cohort studies[J]. J Pediatr Gastroenterol Nutr, 2020, 71 (3): e84- e89. |
| 25 | Peyrin-Biroulet L , Panés J , Sandborn WJ , et al. Defining disease severity in inflammatory bowel diseases: Current and future directions[J]. Clin Gastroenterol Hepatol, 2016, 14 (3): 348- 354. |
| 26 | Kane S , Lemieux N . The role of breastfeeding in postpartum disease activity in women with inflammatory bowel disease[J]. Am J Gastroenterol, 2005, 100 (1): 102- 105. |
| 27 | Ananthakrishnan AN , Bernstein CN , Iliopoulos D , et al. Environmental triggers in IBD: A review of progress and evidence[J]. Nat Rev Gastroenterol Hepatol, 2018, 15 (1): 39- 49. |
| 28 | Gubatan J , Nielsen OH , Levitte S , et al. Biologics during pregnancy in women with inflammatory bowel disease and risk of infantile infections: A systematic review and meta-analysis[J]. Am J Gastroenterol, 2021, 116 (2): 243- 253. |
/
| 〈 |
|
〉 |